The healthcare community is intrigued by retatrutide, a new dual GIP and GLP-1 receptor that’s showing significant results in early research. This compound works by imitating natural hormones to regulate appetite and increase feelings of satisfaction , ultimately leading substantial body decrease. While currently under investigation and not readi